Alembic Pharma gets USFDA nod for overactive bladder treatment drug
Posted by
www.biotecnika.org
The company has received approval from the USFDA for its abbreviated
new drug application (ANDA) Solifenacin Succinate tablets in the
strengths of 5 mg and 10 mg.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-gets-usfda-nod-for-overactive-bladder-treatment-drug/articleshow/69423547.cms
Subscribe to:
Post Comments (Atom)
Post a Comment